BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fabricius D, Ludwig C, Scholz J, Rode I, Tsamadou C, Jacobsen EM, Winkelmann M, Grempels A, Lotfi R, Janda A, Körper S, Adler G, Debatin KM, Schrezenmeier H, Jahrsdörfer B. mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Vaccines (Basel) 2021;9:918. [PMID: 34452043 DOI: 10.3390/vaccines9080918] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsamadou C, Ludwig C, Scholz J, Proffen M, Hägele J, Rode I, Körper S, Fabricius D, Jahrsdörfer B, Neuchel C, Amann E, Schrezenmeier H, Fürst D. Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.999693] [Reference Citation Analysis]
2 Ferreira IA, Lee CY, Foster W, Abdullahi A, Tuong ZK, Stewart BJ, Ferdinand JR, Guillaume S, Potts MO, Perera M, Krishna BA, Alonso AP, Cabantous M, Kemp SA, Ceron-gutierrez L, Ebrahimi S, Lyons P, Smith KG, Bradley J, Collier DA, Teichmann SA, Mccoy LE, Macary PA, Doffinger R, Wills MR, Linterman M, Clatworthy MR, Gupta RK, The CITIID-NIHR BioResource COVID-19 Collaboration. Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly.. [DOI: 10.1101/2022.10.13.22281024] [Reference Citation Analysis]
3 Laham G, Martínez AP, Rojas Gimenez W, Amaya L, Abib A, Echegoyen N, Díaz C, Lucero A, Martelli A, Videla C, Neukam K, Di Lello FA. Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients. J Nephrol 2022. [PMID: 36152219 DOI: 10.1007/s40620-022-01446-2] [Reference Citation Analysis]
4 Rana R, Kant R, Huirem RS, Bohra D, Ganguly NK. Omicron variant: Current insights and future directions. Microbiol Res 2022;265:127204. [PMID: 36152612 DOI: 10.1016/j.micres.2022.127204] [Reference Citation Analysis]
5 Medina-Pestana J, Almeida Viana L, Nakamura MR, Lucena EF, Granato CFH, Dreige YC, Amorim LVP, Chow CYZ, Demarchi Foresto R, Roberto Requião-Moura L, Tedesco-Silva H, Cristelli MP. Immunogenicity After a Heterologous BNT262b2 Versus Homologous Booster in Kidney Transplant Recipients Receiving 2 Doses of CoronaVac Vaccine: A Prospective Cohort Study. Transplantation 2022. [PMID: 35939382 DOI: 10.1097/TP.0000000000004260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Albanesi B, Godono A, Comoretto RI, Casabona E, Curoso G, Leone MV, Milanesio N, Mirra I, Montrucchio G, Pittaluga F, Cavallo R, Clari M, Ciocan C. Immune Response of a Heterologous mRNA-1273 Second-Dose Immunization after a First Dose of ChadOx1 against SARS-CoV-2: A Cross-Sectional Study. Vaccines 2022;10:1241. [DOI: 10.3390/vaccines10081241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Townsend JP, Hassler HB, Sah P, Galvani AP, Dornburg A. The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2. Proc Natl Acad Sci U S A 2022;119:e2204336119. [DOI: 10.1073/pnas.2204336119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen Y, Cheng P, Huang W, Chen H, Chen H, Chen J, Lin C, Tang K, Hung W, Hsieh T, Chen Y, Chen Y, Hsiao T. Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases. Front Immunol 2022;13:920865. [DOI: 10.3389/fimmu.2022.920865] [Reference Citation Analysis]
9 Edwards DK, Carfi A. Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects. Current Opinion in Immunology 2022;77:102214. [DOI: 10.1016/j.coi.2022.102214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jahrsdörfer B, Proffen M, Scholz J, Hägele J, Ludwig C, Vieweg C, Grempels A, Fabricius D, Lotfi R, Körper S, Adler G, Schrezenmeier H. BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages. Front Immunol 2022;13:920210. [DOI: 10.3389/fimmu.2022.920210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Burnouf T, Gathof B, Bloch EM, Bazin R, de Angelis V, Patidar GK, Rastvorceva RMG, Oreh A, Goel R, Rahimi-levene N, Hindawi S, Al-riyami AZ, So-osman C. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins against SARS-CoV-2. Transfusion Medicine Reviews 2022. [DOI: 10.1016/j.tmrv.2022.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Shao W, Zhang W, Fang X, Yu D, Wang X. Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures. J Microbiol Immunol Infect 2022;55:387-94. [PMID: 35501267 DOI: 10.1016/j.jmii.2022.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Laham G, Martínez AP, Gimenez WR, Amaya L, Abib A, Echegoyen N, Díaz C, Lucero A, Martelli A, Videla C, Neukam K, Di Lello FA. Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients.. [DOI: 10.1101/2022.05.13.22275049] [Reference Citation Analysis]
14 Pereson MJ, Amaya L, Neukam K, Bare P, Echegoyen N, Noel Badano M, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Heterologous gam-covid-vac (sputnik V) / mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis. Clin Microbiol Infect 2022:S1198-743X(22)00265-8. [PMID: 35595128 DOI: 10.1016/j.cmi.2022.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Pereson MJ, Amaya L, Neukam K, Bare P, Echegoyen N, Badano MN, Lucero A, Martelli A, Garcia GH, Videla C, Martínez AP, Di Lello FA. Heterologous Gam-COVID-Vac (Sputnik V) / mRNA-1273 (Moderna) vaccination induces a stronger humoral response than homologous Sputnik V in a real-world data analysis.. [DOI: 10.1101/2022.04.08.22273532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Nguyen TT, Quach THT, Tran TM, Phuoc HN, Nguyen HT, Vo TK, Vo GV. Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine. Biomedicine & Pharmacotherapy 2022;147:112650. [DOI: 10.1016/j.biopha.2022.112650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
17 Romero-pinedo S, Quesada M, Horndler L, Álvarez-fernández S, Olmo A, Abia D, Alarcón B, Delgado P. Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein. Front Immunol 2022;13:809285. [DOI: 10.3389/fimmu.2022.809285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol 2022;12:821538. [DOI: 10.3389/fimmu.2021.821538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
19 Richardson CD. Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19. Lancet 2022;399:3-5. [PMID: 34883051 DOI: 10.1016/S0140-6736(21)02757-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV2 Study Group. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet 2022;399:36-49. [PMID: 34883053 DOI: 10.1016/S0140-6736(21)02718-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 42] [Article Influence: 68.0] [Reference Citation Analysis]
21 Romero-pinedo S, Quesada M, Álvarez-fernández S, Olmo A, Abia D, Alarcón B, Delgado P. Longitudinal and comparative analysis of humoral response upon COVID-19 vaccination.. [DOI: 10.1101/2021.10.14.21264762] [Reference Citation Analysis]
22 Colucci M, De Santis E, Totti B, Miroballo M, Tamiro F, Rossi G, Piepoli A, De Vincentis G, Greco A, Mangia A, Cianci R, Di Mauro L, Miscio G, Giambra V. Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA Vaccine. Vaccines (Basel) 2021;9:1207. [PMID: 34696315 DOI: 10.3390/vaccines9101207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Jahrsdörfer B, Fabricius D, Scholz J, Ludwig C, Grempels A, Lotfi R, Körper S, Adler G, Schrezenmeier H. BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents. Front Immunol 2021;12:743422. [PMID: 34659239 DOI: 10.3389/fimmu.2021.743422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
24 Manolescu LSC, Zaharia CN, Dumitrescu AI, Prasacu I, Radu MC, Boeru AC, Boidache L, Nita I, Necsulescu A, Chivu RD. Early COVID-19 Vaccination of Romanian Medical and Social Personnel. Vaccines (Basel) 2021;9:1127. [PMID: 34696235 DOI: 10.3390/vaccines9101127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]